A Class II Special Controls Guideline about John Cunningham Virus Serological Reagents has recently been posted. This document was developed to support the classification of the John Cunningham Virus (JCV) serological reagents for the risk stratification for progressive multifocal leukoencephalopathy (PML) development into class II (special controls).
Who Is at Risk for Prostate Cancer? | CDC
Hace 18 horas